Quantcast

Latest Biosimilar Stories

2014-03-27 12:30:38

DUBLIN, Mar. 27, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/rwdz5w/therapy_class ) has announced the addition of the "Therapy Class Overview: Rituximab biosimilar" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Approval of Inflectra/Remsima, the first biosimilar Monoclonal antibody (Mab) from Celltrion and Hospira in EU in 2013 is a trend setter! Inflectra is a biosimilar of Johnson & Johnson's Remicade,...

2014-03-27 08:33:57

DUBLIN, Mar. 27, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/x6dsmh/therapeutic_class) has announced the addition of the "Therapeutic Class Overview : Emergence of Biogenerics Era In Japan - It's Time to Welcome Antibody Biosimilars of Foreign Origins Soon" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) With three products and eight players already in market - Japan biosimilar market will enter new phase...

2014-03-26 12:28:52

This Strategic Informational Event Will Assess the Global and EU-specific Competitive Landscape and Commercial Opportunities and Barriers BURLINGTON, Mass., March 26, 2014 /PRNewswire/ -- Decision Resources Group conducts extensive primary and secondary market research on the biosimilars space globally and within Europe and will be sharing key insights and analysis in a content-rich, one-day seminar. http://photos.prnewswire.com/prnvar/20130103/MM36768LOGO The Competitive Landscape Seminar:...

2014-03-25 23:04:58

Global regulators, industry professionals and academia will gather at the event in Miami, Florida from May 14 to 15 to discuss the current regulatory landscape, future research and drug development in Latin America. Washington, DC (PRWEB) March 25, 2014 Twelve regulatory authorities from around the world will be among attendees discussing the opportunities provided by collaborating to achieve harmonization in regulation at the Latin American Regulatory Conference (LARC) 2014. Global...

2014-03-25 23:04:25

Experts in industry, research and pharma will discuss complex drug market and regulation. Horsham, Pa. (PRWEB) March 25, 2014 Leaders in biosimilar innovation will provide an in-depth, comparative analysis of the current global debates and trends in biosimilar regulation at the DIA 2014 50th Annual Meeting, from June 15 to 19 at the San Diego Convention Center. The “Trends in Biosimilars Regulation Within Developed and Emerging Markets” session will be held on June 19 at 10:45 a.m....

2014-03-18 23:01:55

The 26th annual EuroMeeting, coming to Austria’s capital from 25-27 March, will feature more than 100 sessions in 16 parallel themes and the chance to hear from 300+ expert speakers, including representatives from the European Medicines Agency (EMA), the European Commission and regulatory agencies from around the world. BASEL, SWITZERLAND (PRWEB) March 18, 2014 In less than one week’s time more than 2,500 professionals from around the world will gather in Vienna at DIA’s largest...

2014-03-14 04:20:45

REYKJAVIK, Iceland, March 14, 2014 /PRNewswire/ -- Alvotech, a powerful new player in the field of biopharmaceuticals and Finesse Solutions, Inc. ("Finesse"), today announce that they have entered into a partnership that will provide Alvotech with world-class, scalable, flexible and cost-efficient manufacturing and laboratory technology through the Finesse turnkey SmartFactory® GMP manufacturing platform suite. SmartFactory® is a single-use cGMP bio-manufacturing capacity, which...

2014-03-13 16:27:50

DUBLIN, Ireland, March 13, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/34kmnx/global_biosimilar) has announced the addition of the "Global Biosimilar Market Outlook 2018" [http://www.researchandmarkets.com/research/34kmnx/global_biosimilar ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global biosimilars market is at a crucial turning point, as...

2014-03-13 08:29:59

MUNICH, March 13, 2014 /PRNewswire/ -- Formycon AG has expanded its Advisory Board. With Dr. Bernhard Hampl, a top pharmaceuticals manager from the US has been acquired for the advisory body. Over the past 20 years, Dr. Bernhard Hampl was a successful CEO in large American generics companies such as EON LABS Inc. and later Sandoz US, which after fusion of the two companies became America's second-largest manufacturer of generics. Dr. Hampl, who started his...

2014-03-12 20:24:16

DUBLIN, March 12, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the United States District Court for the Eastern District of Virginia has ruled that United States Patent No. RE44,048 (the '048 Patent) is invalid. Actavis was earlier sued by Plaintiffs G.D. Searle LLC and Pfizer Asia Pacific PTE, Ltd. for infringement of the '048 Patent in connection with its Abbreviated New Drug Application directed to Actavis' generic version of Pfizer's Celebrex® (celecoxib)...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related